Skip links

Health Outcomes Observatory (H2O)

In Silico World: Lowering barriers to ubiquitous adoption of In Silico Trials (ISW)

INnate-ImmunomeTabolIsm as Antiviral TargEt (INITIATE)

Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences (MOLCARUTUC)

GEnomics of MusculoSkeletal traits TranslatiOnal Network (GEMSTONE)

Development of a radiolabeled necrosis-targeting probe for early detection of anti-cancer therapy efficacy and anti-cancer treatment: a new theranostic platform

Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity (B2B)

Developing a validated Cancer-on-Chip prototype for personalized medicine

Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY (HARMONY)

Phase I-II study with pixantrone, etoposide, bendamustine and rituximab in patients with relapsed aggressive B- or T-cell non-Hodgkin’s lymphoma